Anti-CD6-blocked ricin: An anti-pan T-cell immunotoxin

This publication has 23 references indexed in Scilit:

• Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion
  Blood, 1992
• The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins.
  The Journal of Experimental Medicine, 1991
• Monoclonal anti-T cell (T12) antibody treatment of graft-versus-host disease in severe combined immunodeficiency: targeting of antibody and activation of complement on CD8+ cytotoxic T cell surfaces
  Journal of Allergy and Clinical Immunology, 1991
• T CELL DEPLETION WITH ANTI-CD5 IMMUNOTOXIN IN HISTOCOMPATIBLE BONE MARROW TRANSPLANTATION
  Transplantation, 1990
• Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid- resistant acute graft-versus-host disease
  Blood, 1990
• Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis
  Journal of Cellular Physiology, 1989
• Measurement of cytotoxicity by target cell release and retention of the fluorescent dye bis-carboxyethyl-carboxyfluorescein (BCECF)
  Journal of Immunological Methods, 1988
• TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH MONOCLONAL ANTI-T12 ANTIBODY1,2
  Transplantation, 1983
• Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice
  British Journal of Cancer, 1976
• The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassay
  Biochemical Journal, 1973